Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody

Assignee

• Tusk Therapeutics
• Cancer Research Technology Limited

Inventors

• Anne Goubier (21 patents)
• Josephine Salimu (19 patents)
• Kevin Moulder (23 patents)
• Beatriz Goyenechea Corzo (19 patents)
• Pascal Merchiers (19 patents)
• Sergio Quezada (19 patents)
• Karl Peggs (2 patents)
• Frederick Arce Vargas (1 patents)
• Isabelle Solomon (1 patents)

View full patent text on Google Patents →